Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-31 @ 2:40 PM
Study NCT ID:
NCT01715233
Status:
COMPLETED
Last Update Posted:
2019-03-15
First Post:
2012-10-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12
Start Date Type:
ACTUAL
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-24
First Submit QC Date:
None
Study First Post Date:
2012-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-19
Results First Submit QC Date:
None
Results First Post Date:
2019-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-14
Last Update Post Date:
2019-03-15
Last Update Post Date Type:
ACTUAL